Pharming Group NV (PHAR) — Cash Flow-to-Debt Ratio
Pharming Group NV (PHAR) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $1.63 Million could theoretically repay 0% of its total liabilities ($220.41 Million) in one year. See financial flexibility index of Pharming Group NV to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharming Group NV Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Pharming Group NV across 21 annual periods. For the full cash flow conversion analysis, see Pharming Group NV operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Pharming Group NV (2005–2025)
Year-by-year debt coverage analysis for Pharming Group NV. Check Pharming Group NV (PHAR) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | $50.07 Million | $222.79 Million | ▲ +2340.0% |
| 2024 | -0.01x | $-1.79 Million | $178.92 Million | ▲ +85.8% |
| 2023 | -0.07x | $-17.30 Million | $244.07 Million | ▼ -169.8% |
| 2022 | 0.10x | $22.46 Million | $221.16 Million | ▼ -45.2% |
| 2021 | 0.19x | $37.84 Million | $204.40 Million | ▼ -57.4% |
| 2020 | 0.43x | $83.63 Million | $192.39 Million | ▼ -18.8% |
| 2019 | 0.54x | $74.15 Million | $138.53 Million | ▲ +102.6% |
| 2018 | 0.26x | $46.19 Million | $174.81 Million | ▲ +1.9% |
| 2017 | 0.26x | $45.84 Million | $176.82 Million | ▲ +357.4% |
| 2016 | -0.10x | $-10.52 Million | $104.45 Million | ▲ +79.2% |
| 2015 | -0.49x | $-17.95 Million | $37.00 Million | ▼ -137.9% |
| 2014 | -0.20x | $-6.42 Million | $31.46 Million | ▲ +35.1% |
| 2013 | -0.31x | $-11.45 Million | $36.45 Million | ▲ +25.1% |
| 2012 | -0.42x | $-13.58 Million | $32.40 Million | ▲ +30.9% |
| 2011 | -0.61x | $-20.34 Million | $33.55 Million | ▼ -218.4% |
| 2010 | -0.19x | $-6.89 Million | $36.16 Million | ▲ +57.4% |
| 2009 | -0.45x | $-27.24 Million | $60.99 Million | ▼ -138.7% |
| 2008 | -0.19x | $-14.21 Million | $75.96 Million | ▲ +31.4% |
| 2007 | -0.27x | $-31.69 Million | $116.14 Million | ▲ +59.3% |
| 2006 | -0.67x | $-25.89 Million | $38.59 Million | ▲ +69.5% |
| 2005 | -2.20x | $-15.26 Million | $6.93 Million | — |